| Title | Nitrous oxide for conscious sedation in pediatric dentistry | ||
| Authors | E. Tsirella and M. Mironidou-Tzouveleki
A΄ Laboratory of Pharmacology, Medical School, Aristotle University, Thessaloniki, Greece |
||
| Citation | Tsirella, E., Mironidou-Tzouveleki, M.: Nitrous oxide for conscious sedation in pediatric dentistry, Epitheorese Klin. Farmakol. Farmakokinet. 22(2): 350-352 (2008) | ||
| Publication Date | 23-25 May 2008 | ||
| Full Text Language | English | ||
| Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
||
| Keywords | Nitrous oxide, pediatric dentistry, conscious sedation. | ||
| Other Terms | Review article | ||
| Summary | Nitrous oxide (Ν2Ο) is an inhaled anesthetic actually used for conscious sedation in pediatric dentistry. It is a colorless and odorless gas with a rather sweet taste. Its action is mediated via the dopaminergic, alpha-2 adrenergic, NMDA and benzodiazepine receptors. It is characterized by a very low liposolubility, is not metabolized by the organism, has no affinity for any particular tissue and is not stored anywhere in the body. It is rapidly absorbed in the alveolar tissue, resulting in immediate sedation. Because of its rapid elimination, the patient can be dismissed shortly after the end of the inhalation. Its adverse effects are very limited. In pediatric dentistry, nitrous oxide is administrated in the hospital setting and is particularly indicated for very anxious children or children with special needs. | ||
| References | 1. Bennaceur S., Sagnet P., Ernewein D., Maudier C., Louafi S., Couly G. : Anesthésies locale, locorégionale et générale en odontologie et stomatologie pédiatriques. Encycl. Méd. Chir. 23-400-G-10: 9-12 (2001)
2. Delbos Y., Nancy J., Parfait S., Cluzel P., Dorignac G.: Le MEOPA: Propriétés et mécanismes d’action. J. Odontostomatol. Ped. 11: 121-130 (2004) 3. Mennerick S., Jevtovic-Todorovic V., Todorovic S.M., Shen W., Olney J.W., Zorumski C.F.: Effect of nitrous oxide on excitatory inhibitory synaptic transmission in hippocampal cultures. J. Neurosci. 18: 9716-9726 (1998) 4. Thompson P.L., Lown B.: Nitrous oxide as an analgesic in acute myocardial infarction. J. Am. Med. Assoc. 235: 924-927 (1976) 5. Kingery W.S., Sawamura S., Agache G.S., Davies M.F., Clark J.D., Zimmer A.: Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/ hypnotic effects of nitrous oxide. Eur. J. Pharmacol. 427: 27-35 (2001) 6. Zhang C., Davies M.F., Guo T.Z., Maze M.: The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord. Anesthesiology 91: 1401-1407 (1999) 7. Fujinaga M., Bden J.M., Yhap E.O., Mazze R.I.: Reproductive and teratogenic effects of nitrous oxide, isoflurane and their combination in rats. Anesthesiology 67: 690-694 (1987) 8. Fujinaga M.: Teratogenicity of nitrous oxide. Best Pract. Res. Clin. Anesth. 15: 363-375 (2001) 9. Prévenir les expositions professionnelles aux gaz et vapeurs anesthésiques. Document réalisé par le groupe pluridisciplinaire Anesthésie et qualité de l’air. L’assurance maladie, caisse régionale d’Île-de-France 10. Annequin D., Murat I.: Bonnes pratiques pour l’utilisation, à titre d’antalgique, du mélange équimolaire oxygène-protoxyde d’azote (Entonoxt) chez l’enfant. Ann. Fr. Anesth. Réanim. 17: 160-163 (1998) |
||
| Relative Papers | |||
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
| ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2008 – ANNUAL SUBSCRIPTION 2008 | |
| Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
| Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
| Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |
|